Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN1A | P35498 | 2/20 | 0.46 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.46 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.45 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.45 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.45 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.41 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.41 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31532234 | 1.00 | SCN1A (0.46) | SCN1ASCN2ASCN3AHTTCYP2D6 | |
| SCHEMBL24469980 | 0.87 | HTT (0.45) | HTTCYP2D6CHRM3CHRM5CHRM1 | |
| SCHEMBL24469943 | 0.86 | HTT (0.44) | HTTCYP2D6CHRM3CHRM5CHRM1 | |
| SCHEMBL24469706 | 0.86 | HTT (0.44) | HTTCYP2D6CHRM3CHRM5CHRM1 | |
| SCHEMBL30585534 | 0.85 | HTT (0.45) | HTTCYP2D6CHRM3CHRM5CHRM1 | |
| SCHEMBL24469944 | 0.85 | HTT (0.45) | HTTCYP2D6CHRM3CHRM5CHRM1 | |
| SCHEMBL30585528 | 0.84 | RAB9A (0.40) | HTTCYP2D6CHRM3CHRM5CHRM1 | |
| SCHEMBL27125777 | 0.84 | RAB9A (0.40) | HTTCYP2D6CHRM3CHRM5CHRM1 | |
| SCHEMBL24469707 | 0.84 | RAB9A (0.40) | HTTCYP2D6CHRM3CHRM5CHRM1 | |
| SCHEMBL24469982 | 0.83 | MEN1 (0.42) | SCN1ASCN2ASCN3AHTTCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12606549-B2 | Anticholinergic agents | REZUBIO PHARMACEUTICALS CO., LTD (CN) | 2026-04-21 | — | — | US | disclosed |
| US-20240002372-A1 | ANTICHOLINERGIC AGENTS | REZUBIO PHARMACEUTICALS CO., LTD (CN) | 2024-01-04 | — | — | US | disclosed |
| WO-2022111500-A1 | ANTICHOLINERGIC AGENTS | REZUBIO PHARMACEUTICALS CO., LTD (CN) | 2022-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240002372-A1 | ANTICHOLINERGIC AGENTS | CHRM3, CHRM2, CHRM1 | SCN1A 527/4885SCN2A 820/4885SCN3A 239/4885 |
| US-12606549-B2 | Anticholinergic agents | CHRM1, CHRNA1, CHRND | SCN1A 132/4885SCN2A 310/4885SCN3A 196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.